Prostate Cancer Therapeutics Market to 2019

Information about Prostate Cancer Therapeutics Market to 2019

Published on July 31, 2014

Author: petepaul7

Source: authorstream.com

Content

Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 : Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 Published: November 2013 Single User PDF: US$ 3500 Corporate User PDF : US$ 10500 Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 1 © ReportsnReports.com / Contact [email protected] Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 : Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 Reasons to Buy : Understand the different levels of prostate cancer therapies, from early-stage prostate cacner to metastatic and castrate-resistant prostate cancer. Understand the vast scope and diversity of the pipeline, including which molecule types and mechanisms of action are prominent. Observe the trends in clinical trial duration and size amongst clinical Phases, between molecule types and mechanisms of action, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for Prostate Cancer Therapeutics . Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the prostate cancer therapeutics market. The recent approvals are anticipated to generate strong revenues during the forecast following increasing uptake by physicians as the treatment algorithm shifts towards their first-line usage over Taxotere . Additionally, a very large late-stage pipeline is anticipated to produce a number of new market entrants which are superior to existing products. Overall, this is anticipated to drive rapid market growth from $4.1 billion in 2012 to $8.0 billion by 2019 at a CAGR of 10.1%. Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 2 © ReportsnReports.com / Contact [email protected] Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 : Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 Scope of the report: A brief introduction to prostate cancer, including the disease‚Äôs pathogenesis, risk factors, diagnosis, staging and treatment algorithms for each stage. In-depth analysis of drugs available for the treatment of prostate cancer, including analyses of their safety, efficacy, treatment patterns and strengths/weaknesses. Includes a heat map comparing the drugs in terms of safety and efficacy. Comprehensive review of the pipeline for prostate cancer therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. Multi-scenario forecast data of the market to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs and the changes in disease epidemiology across the key developed markets including the US, Japan, Germany, the UK, France, Italy and Spain. Complete report of 107 Pages is available @ http://www.reportsnreports.com/reports/270793-prostate-cancer-therapeutics-market-to-2019-rising-prevalence-and-strong-uptake-of-recent-approvals-to-drive-robust-growth-to-2019.html . Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 3 © ReportsnReports.com / Contact [email protected] Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 : Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 Few Points from Table of Contents: 3 Marketed Products 19 3.1 Hormonal Therapies 19 3.2 Chemotherapy agents 24 3.3 Therapeutic Vaccines 26 3.4 Targeted therapies (Second Generation Anti-androgens) 27 3.5 Bone Metastasis Treatments 28 3.6 Heat Map for Marketed Products 30 4 Prostate Cancer Developmental Pipeline 33 4.1 Overall Pipeline 33 4.2 Mechanisms of Action 35 4.3 Clinical Trials 36 4.4 Key Late-Stage Pipeline Molecules 43 Single User License: US $ 3500 Inquire For Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=270793 . Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 4 © ReportsnReports.com / Contact [email protected] Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 : Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019 5 Market Forecast to 2019 47 5.1 Global 47 5.2 North America 50 5.3 Five European Markets 54 5.4 Japan 58 6 Prostate Cancer Therapeutics: Drivers and Barriers 60 6.1 Drivers 60 6.2 Barriers 61 7 Licensing and Co-development Deals Analysis 62 7.1 Licensing Deals 62 7.2 Co-Development Deals 68 Buy a copy of this report by GBI Research @ http://www.reportsnreports.com/purchase.aspx?name=270793 . Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 5 © ReportsnReports.com / Contact [email protected]

Related presentations


Other presentations created by petepaul7

Vital Signs Monitoring Market
11. 07. 2014
0 views

Vital Signs Monitoring Market

Battery Materials Market
21. 07. 2014
0 views

Battery Materials Market